Clinical improvement of a toddler with COVID-19 focal cerebral arteriopathy possibly due to intra-arterial nimodipine

Dekel Avital, Shlomi Peretz, Eliauh Perlow, Osnat Konen, Edna Inbar, Yarden Bulkowstein, Elhanan Nahum, Sharon Aharoni, Lital Cohen Vig, Yoram Nevo, Eitan Auriel, Rachel Straussberg*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Pediatric stroke is considered an infrequent complication of COVID-19. Focal cerebral arteriopathy (FCA) is one of the most common causes of arterial ischemic stroke in a previously healthy child. The present report describes a toddler with FCA most likely induced by SARS-CoV-2 infection who showed significant clinical improvement that may be related to injection of intra-arterial nimodipine. To our knowledge, this is the first reported use of nimodipine in this setting.

Original languageEnglish
Pages (from-to)40-43
Number of pages4
JournalEuropean Journal of Paediatric Neurology
Volume40
DOIs
StatePublished - Sep 2022

Fingerprint

Dive into the research topics of 'Clinical improvement of a toddler with COVID-19 focal cerebral arteriopathy possibly due to intra-arterial nimodipine'. Together they form a unique fingerprint.

Cite this